← Leaderboards
Paulo Lusso
Osel, Inc.
$1,013,707
Attributed
$1,013,707
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $297.3K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,013,707 · 1
By mechanism
U19$1,013,707 · 1
Top collaborators
No co-investigators on record.
Most similar at Osel, Inc.
Same institution · by research overlap
- Laurel A. Lagenaur$6,537,797
- Patrick K Martin$2,280,763
- Qiang Xu$2,686,315
- John A Lewicki$973,154
- Thomas P Parks$678,082
Others in their field
Top investigators on “Chemokine”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Andrew D Luster · Massachusetts General Hospital$27,938,802
- Joan Weinberger Berman · Yeshiva University$24,229,643
- Larry Arthur$22,516,306
- Maurizio Fava · Massachusetts General Hospital$19,116,294
- Lionel B Ivashkiv · Hospital For Special Surgery$18,420,856
Research focus
ChemokineHiv InfectionsChemokine ReceptorDrug Design /Synthesis /ProductionLactobacillusVaginaAntiviral AgentsAntibodiesAgonistBiotechnologyBiotherapeutic AgentCalcium FluxCcr5 GeneCd4 AntigensBinding (Molecular Function)Antiaids AgentChemokine (C-C Motif) Receptor 5BaseChemotaxisChromosomesChromosomes, BacterialClinical ResearchClinical TrialsCd4 Positive T Lymphocytes